A drug widely used to treat type 2 diabetes may have unintended effects on the pancreas that could lead to a form of low-grade pancreatitis in some patients and a greater risk of pancreatic cancer in long-term users. Sitagliptin, sold in pill form as Januvia, caused abnormalities in the pancreas that are recognized as risk factors for pancreatitis and, with time, pancreatic cancer in humans.
Full article >>
Friday, May 1, 2009
Popular Diabetes Treatment Could Trigger Pancreatitis, Pancreatic Cancer, Study Suggests
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment